Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTL78 for Intraoperative Imaging of Prostate Cancer
NCT07725523Phase 3Recruiting
- Start
- Dec 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of zopocianine in prostate cancer (PCa). Planned start Dec 2026; status: recruiting.
02
Drugs
zopocianine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07725523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07725523.